-
TILs in Solid TumorsWith the FDA’s approval of the first tumor‑infiltrating lymphocyte (TIL) therapy to treat advanced melanoma, researchers seek to expand this type of cellular therapy to other solid tumors.
by Kendall K. Morgan
-
Forward Look
The Time FactorOncologist and researcher Arjun Gupta discusses time toxicity and why it is important.
by Ashley P. Taylor
-
Forward Look
Imaging Predicts Early Response to Melanoma ImmunotherapyResearch shows a scan can reveal treatment responses just one week after people with melanoma start immunotherapy.
by Anna Azvolinsky
-
Forward Look
A Different Chemotherapy Approach for Ovarian CancerStudy suggests heated chemotherapy delivered to the abdominal cavity extends survival in advanced ovarian cancer.
by Kris Conner
-
Forward Look
Some Breast Cancer Patients Can Skip RadiationResearch suggests postmenopausal women over 50 with low-risk hormone receptor-positive breast cancer may forgo radiation after surgery.
by Darcy Lewis
-
From the Editor-in-Chief
Weight-loss Drugs and CancerObesity and increased cancer risk have been linked. Could new drugs promising to reduce weight also lower the risk of cancer?
by William G. Nelson, MD, PhD
-
To Understand Disparities, Look at the Broader ContextsResearchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
Regular Aspirin Use May Help Fight Colorectal CancerAspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
Progress Against CancerNew research fuels progress in cancer survival, prevention and side effect management.
-
Vaccines Spark Activity in Pancreatic CancerScientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
